insights_auto
Why is ALCOX down 5.75%?
Dive Deeperchevron_right
ALCOX:EPA
NicOx SA
€0.30
arrow_downward
-5.75%(-0.018) 1D
Oct 8, 5:35:15 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALCOX...
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
29.31M
Avg. vol.
165.85K
Volume
250.70K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
Open
€0.31
High
€0.31
Low
€0.30
Mkt. cap
29.31M
Avg. vol.
165.85K
Volume
250.70K
52-wk high
€0.57
52-wk low
€0.28
EPS
-€0.03
Shares outstanding
97.55M
No. of employees
10
News stories
From web sources and news partners
ChartMill
·
27 minutes ago
Exploring the top movers within the dow jones index during today's session.
Forbes
·
1 hour ago
The S&P 500 Yields Barely 1%. Income Investors Need A New Playbook
Traders Union
·
32 minutes ago
Dow Jones, S&P 500, and Nasdaq all end down, Peter Tuchman notes
Profile
Nicox S.A. is a French ophthalmology company developing treatments to maintain vision and improve ocular health. Nicox is headquartered in Sophia Antipolis, France, and its Chairman and CEO is Michele Garufi.
Nicox is listed on Euronext Paris and is part of the CAC Healthcare, CAC Pharma & Bio and Next 150 indexes. Its pipeline includes three programs in development, and it has two U.S. Food and Drug Administration approved products. Wikipedia
About NicOx SA
CEO-
Employees10
Founded1996
HeadquartersValbonne, Provence-Alpes-Côte d'Azur, France
SectorBiotechnology
Websitenicox.com